Earth Science Tech (ETST) Reports 8% Revenue Growth for Fiscal 2026
The healthcare holding company posted higher earnings and positive operating cash flow while repurchasing over 7 million shares.
By the FiledFeed automated desk
This summary was generated by AI from the company's SEC filing and may contain errors — always verify against the primary source on SEC.gov.
The short version
Earth Science Tech reported fiscal year 2026 revenue of $35.7 million, up 8% from the prior year, with net income rising 11% to $3.6 million. The company generated positive operating cash flow, strengthened its balance sheet without adding debt, and repurchased and retired more than 7.1 million shares of common stock during the fiscal year and into the first quarter of 2027.
Filing impact
Filing sentiment
Earth Science Tech, Inc. (ETST), a holding company focused on acquiring and scaling healthcare businesses, reported fiscal year-end results on June 18, 2026, showing steady growth across key metrics.
For the 12-month period ended March 31, 2026, the company reported revenue of $35.7 million, an 8% increase compared to $33.1 million in the prior year. Net income grew 11%, rising to $3.6 million from $3.3 million. Gross profit increased 5% to $25.5 million, compared with $24.3 million.
The company's balance sheet improved over the year. Total assets grew 27% to $9.0 million as of March 31, 2026, from $7.1 million a year earlier. Earth Science Tech reported generating positive operating cash flow and did not add debt to its balance sheet during the fiscal year.
The company repurchased and retired 4,023,296 shares of common stock during the fiscal year ended March 31, 2026. Chief Executive Officer Giorgio R. Saumat noted that including buybacks after year-end, more than 7.1 million shares have been retired in total. In the first quarter of fiscal 2027 (the quarter ended June 30, 2026), the company repurchased an additional 3.1 million shares.
Saumat attributed the results to progress integrating the company's healthcare platform, which combines telemedicine, pharmacy, clinical support, and direct-to-patient fulfillment services. He said the company is "still in the early stages of what this business can become" and plans to continue an "aggressive share buyback program" while investing in new products and expanding its healthcare platform.
Key facts
- Earth Science Tech (ticker: ETST) reported fiscal 2026 results on June 18, 2026
- Revenue: $35.7 million for fiscal 2026, up 8% from $33.1 million in fiscal 2025
- Net income: $3.6 million for fiscal 2026, up 11% from $3.3 million in fiscal 2025
- Gross profit: $25.5 million, up 5% from $24.3 million
- Total assets: $9.0 million as of March 31, 2026, up 27% from $7.1 million
- Repurchased and retired 4,023,296 shares during fiscal 2026
- Total of 7.1 million shares repurchased and retired in fiscal 2026 and subsequent to year-end
- Repurchased 3.1 million shares in first quarter of fiscal 2027
- Generated positive operating cash flow in fiscal 2026
- No debt added to balance sheet during fiscal year
- CEO: Giorgio R. Saumat
Why it matters
ETST's steady revenue and earnings growth, combined with aggressive share buybacks, suggests management confidence in the business model and focus on per-share value. The shift to positive operating cash flow and balance-sheet strengthening (without raising new debt) signals improving financial discipline. However, the company remains small ($35.7 million in annual revenue; $9.0 million in assets), so investors should monitor whether the vertically integrated healthcare platform strategy—which spans telemedicine, pharmacy, and fulfillment—can generate sustainably larger returns than the buyback activity alone.
Frequently asked
- What was Earth Science Tech's revenue growth in fiscal 2026?
- Revenue grew 8% to $35.7 million for the fiscal year ended March 31, 2026, compared with $33.1 million in the prior year.
- How many shares did Earth Science Tech repurchase?
- The company repurchased and retired 4,023,296 shares during fiscal 2026, and more than 7.1 million shares in total when including buybacks after year-end. In the first quarter of fiscal 2027, it repurchased an additional 3.1 million shares.
- Did Earth Science Tech add debt during fiscal 2026?
- No. The company generated positive operating cash flow and did not add debt to its balance sheet during fiscal 2026.
- What business is Earth Science Tech in?
- Earth Science Tech is a holding company that builds a vertically integrated healthcare platform combining telemedicine, compounding pharmacy operations, clinical support, and direct-to-patient fulfillment services, along with investments in real estate, asset management, and consumer products.
What the filing reported
- 2.02 Results of Operations & Financial Condition
- 9.01 Financial Statements & Exhibits
Source
Based on Earth Science Tech, Inc.'s 8-K filed with the SEC on Jun 18, 2026. Read the original filing on SEC.gov ↗